CellRep

CellType

This company develops artificial intelligence agents and biological foundation models to simulate human biology for pharmaceutical and biotechnology drug discovery teams.

CellCo

CellCo develops artificial intelligence and molecular simulation platforms to design programmable biomolecular systems and medicines for the pharmaceutical and biotechnology industries.

Transforming cells into cures

This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.

Cellvoyant

Cellvoyant develops AI-powered imaging platforms and services to predict and optimise stem cell differentiation for biotechnology and pharmaceutical organisations developing cell-based therapies.

Regcell

This biotechnology company develops regulatory T-cell therapies using an epigenetic reprogramming platform to treat patients with autoimmune diseases and inflammatory conditions.

Alp Bio

This company develops a hybrid platform combining human immune organoids and artificial intelligence to assess immunogenicity risks for biotechnology and pharmaceutical drug developers.

ImmuneAGE

This company develops a drug discovery platform for creating therapies that rejuvenate the immune system by targeting hematopoietic stem cells in the bone marrow.

Cellular Intelligence

This company develops artificial intelligence foundation models to predict cell signaling and design cell therapies for pharmaceutical companies and clinical researchers.